CDC approves Pfizer’s COVID vaccine for kids 5 to 11 in the U.S. – CBC

Health Canada continues to review Pfizer’s submission for vaccine’s use in children

Nov 02, 2021

U.S. health officials on Tuesday gave final approval to Pfizer’s kid-sized COVID-19 shot, a milestone that opens a major expansion of the nation’s vaccination campaign to children as young as five.

The U.S. Food and Drug Administration (FDA) already authorized the shots for children ages five to 11 — doses just one-third of the amount given to teens and adults. But the U.S. Centers for Disease Control (CDC) formally recommends who should receive FDA-cleared vaccines.

The announcement by CDC director Dr. Rochelle Walensky came only hours after an advisory panel unanimously decided Pfizer’s shots should be opened to the 28 million youngsters in that age group.

The decision marks the first opportunity for Americans under 12 to get the protection of any COVID-19 vaccine.

“As a mom, I encourage parents with questions to talk to their pediatrician, school nurse or local pharmacist to learn more about the vaccine and the importance of getting their children vaccinated,” Walensky said in a statement Tuesday night.

Read more:

NationTalk Partners & Sponsors Learn More